![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]()
The Hague (AFP) Oct 14, 2008 Cancer patients across Europe face further delays for diagnoses after the owner of a Dutch nuclear reactor said Tuesday it would not re-open until February, almost three months behind schedule. The Petten reactor in northern Holland, which produces a third of the world's medical isotopes, was shut down for safety reasons at the end of August. Last month its owner, the Nuclear Research and Consultancy Group (NRG), said it hoped the reactor would be back in operation by late November. But on Tuesday NRG spokesman Leontien Zuurbier said the repair work was "more complex" than originally thought and gave a new re-opening date of February 16. Activity at the reactor in Petten was suspended following the discovery of air bubbles in the cooling system in August. The closure has led to a shortage of technetium, an isotope made of small quantities of radioactive substance that is used for medical imaging and the treatment of diseases. Technetium is used in 80 percent of diagnoses using radioactive technology. Around seven million check-ups using technetium are made in Europe each year and eight million in the United States, according to NRG. The four other nuclear reactors that produce isotopes for the pharmaceutical industry -- in Canada, France, Belgium and South Africa -- have filled the gap left by the suspension of Petten reactor, Zuurbier said. Community Email This Article Comment On This Article Share This Article With Planet Earth
Related Links Civil Nuclear Energy Science, Technology and News Powering The World in the 21st Century at Energy-Daily.com
![]() ![]() The United States acknowledged Friday it must bridge gaps with its partners over a plan to verify North Korea's nuclear disarmament before it strikes Pyongyang from a US terrorism blacklist. |
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2007 - SpaceDaily.AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement |